| Trial ID: | L5346 |
| Source ID: | NCT00225342
|
| Associated Drug: |
Rosiglitazone
|
| Title: |
Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With Angina
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Angina Pectoris|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Rosiglitazone|DRUG: Gliclazide (Comparison drug)
|
| Outcome Measures: |
Primary: Angina status at 3 months | Secondary: Pulse wave velocity at 3 months|Small vessel function at 3 months|Haemostatic markers at 3 months|Biochemical markers of inflammation at 3 months
|
| Sponsor/Collaborators: |
Sponsor: University of Glasgow | Collaborators: GlaxoSmithKline
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
60
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2006-09-08
|
| Locations: |
Cardiology Department, Glasgow Royal Infirmary, Glasgow, G4 0SF, United Kingdom
|
| URL: |
https://clinicaltrials.gov/show/NCT00225342
|
